This case describes a middle-aged man with anti-dipeptidyl-peptidase-like protein 6 (DPPX) encephalitis who exhibited the triad of memory loss, diarrhea, and tremor. The progression of his disease resembled neurodegenerative disease, and his first presentation at our department was 2 years after ...
Brensocatib is an oral, selective, reversible inhibitor of dipeptidyl peptidase-1 (DPP-1), responsible for activating neutrophil serine proteases (NSPs) including neutrophil elastase (NE), proteinase 3 (PR3), and cathepsin G (CatG). In chronic inflammatory lung diseases such as non-cystic fibros...
中文名称:Recombinant Human Dipeptidyl-Peptidase 4英文名称:Recombinant Human Dipeptidyl-Peptidase 4 产品类别:重组蛋白 中文名称 【DPP4】重组人二肽基肽酶4 英文名字 Recombinant Human Dipeptidyl-Peptidase 4 供应商 ProSpec 产品货号 ENZ-375 产品报价
Dipeptidyl peptidase IV inhibitors: a promising new therapeutic approach for the management of type 2 diabetes. effects of glucagon-like peptide-1 in the treatment of type 2 diabetes has been the development of orally active dipeptidyl peptidase IV inhibitors. Preclin... CF Deacon,JJ Holst - 《...
产品名称:Anti-Dipeptidyl-peptidase 3 Antibody 产品型号: 产品展商:其它品牌 产品文档:无相关文档 简单介绍 Anti-Dipeptidyl-peptidase 3Antibody Anti-Dipeptidyl-peptidase 3 Antibody的详细介绍 Target Function:Involved in autophagic vesicle formation. Conjugation with ATG12, through a ubiquitin-like conjugating ...
The dipeptidyl peptidase-4 (DPP-4) inhibitors Sitagliptin and Vildagliptin lower blood glucose by augmenting endogenous levels of glucagon-like peptide-1 (GLP-1), an incretin which also confers cardioprotection. As such, we hypothesized that treatment with DPP-4 inhibitors are also cardioprotective. ...
Dipeptidyl peptidase IV (DPP IV) is a surface glycoprotein that can degrade glucagon like pepetide-1 (GLP-1) by decreasing blood sugar. Herbal medicines for diabetic therapy are widely used with acceptable efficacy but unsatisfied in advances. DPP IV was chosen as a template to employ molecular...
The physician has now multiple choices to manage his/her patient after secondary failure of metformin, and the question whether it is preferable to add an oral dipeptidylpeptidase-4 (DPP-4) inhibitor (gliptin) or an injectable glucagon-like peptide-1 (GLP-1) receptor agonist will emerge. ...
DPP-4-Hemmer und GLP-1-Rezeptor-Agonisten [GLP: glucagon-like peptide, RA: receptor agonist]) or mainly (DPP-4 inhibitors [DPP: dipeptidylpeptidase]) by enhancing the stimulation of GLP-1 ... Nauck, M. A,Abd El Aziz, M. S,Meier, J. J - 《Der Diabetologe》 被引量: 2发表: 201...
2. Drucker DJ, Nauck MA.: The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet... MA Nauck,RE Ratner,C Kapitza,... - 《Diabetes Care》 被引量: 268发表: 2009年 Dipeptidyl peptidase-4 inhibitors for the treatment of...